Pharmafile Logo
Pharmafocus logo
Advanced Search

Divert money from Herceptin, says radiotherapy leader

November 30, 2007
Sales and Marketing

Money currently being spent on Herceptin for breast cancer patients could be better spent on providing radiotherapy, a leader in …

News

Sanofi and Regeneron sign antibody deal

November 30, 2007
Research and Development

Sanofi-Aventis has increased its stake in Regeneron and will collaborate with the US biotech company on new antibody research.The companies …

News

Short sighted pharma undermining its own future, says Oxfam

November 30, 2007
Sales and Marketing

Pharmaceutical companies are damaging their businesses by blocking access to drugs for millions of people in the developing world, according …

News

Wyeth kidney cancer drug approved in Europe

November 29, 2007
Sales and Marketing

Wyeth's orphan cancer drug Torisel has been approved in Europe for difficult to treat cases of advanced renal cell carcinoma.It …

News

European approval for Merck’s cyanide antidote

November 29, 2007
Sales and Marketing

European regulators have approved Merck Serono's cyanide poisoning cure Cyanokit for use in adults and children. Cyanide poisoning is primarily …

News

Latest news from Datamonitor

November 29, 2007
Research and Development

Medivir to initiate Phase IIa study of hepatitis CMedivir has announced that a Phase IIa study for its investigational hepatitis …

News

Do regional marketing teams really work?

November 29, 2007
Sales and Marketing Europe, marketing, regional marketing

 In this feature, we tackle the subject of the regional marketing team and look at a number of issues, including …

Feature

The new prescriber: friend or foe?

November 22, 2007
Sales and Marketing nursing, pharma, pharmacy, sales

Feature

Champix linked to depression and suicidal thoughts

November 22, 2007
Sales and Marketing reg, safety

Pfizer has alerted US regulator the FDA to cases of depression and suicidal thoughts in patients taking its smoking cessation …

News

Pfizer buys immune system specialists Coley

November 22, 2007
Research and Development

Pfizer is to acquire a company developing new drugs that fight diseases by altering the immune system. The company is …

News

NHS set for major underspend

November 22, 2007

Efforts to save money in the NHS have proved so successful that the health service is set to underspend its …

News

GSK pays $1.65 billion for cardiovascular specialists Reliant

November 22, 2007
Research and Development

News

Ethical dilemma for doctors must be confronted, says bowel cancer charity

November 22, 2007

Many bowel cancer patients are not being informed of all treatment options because their doctors feel embarrassed about having a …

News

Latest news from Datamonitor

November 20, 2007
Research and Development

Aeterna completes enrollment for Phase II trial of lung cancerAeterna Zentaris has completed patient recruitment for its European multi-center Phase …

News

Prexige pulled from UK market

November 20, 2007
Sales and Marketing prexige

Novartis' Prexige has been taken off the market and UK doctors instructed to immediately stop prescribing it following several instances …

News

Private sector schemes axed

November 16, 2007
NHS, private sector

Poor value for money and improvements in the NHS have forced a number of planned private sector schemes to be …

News

Rules on patient groups to change

November 16, 2007
Medical Communications ethics

UK pharma companies have until next July to conform to new rules aimed at making their relations with patient groups …

News

New software aims to cut hospital admissions

November 16, 2007

Doctors and clinicians will have access to a free new computer program that can help them reduce the number of …

News

J&J unveils new ‘comprehensive care’ strategy

November 16, 2007
Sales and Marketing

Johnson & Johnson is to re-model its business operations into more customer-focused units, including a 'comprehensive care' arm that will …

News

GSK scales back US health warnings for Avandia

November 15, 2007
Sales and Marketing

GlaxoSmithKline will update US labelling for its diabetes treatment Avandia to state there is no conclusive evidence linking it to …

News
The Gateway to Local Adoption Series

Latest content

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026

Sandoz’ Ondibta receives European Commission approval for diabetes

January 26, 2026

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026